Professor of biochemistry and of family medication at SUNY Downstate INFIRMARY in Brooklyn.

Biochemistry professor to go over controversies in dietary strategies in diabetes treatment Site is convention of European Association for the analysis of DiabetesRichard Feinman, PhD, professor of biochemistry and of family medication at SUNY Downstate INFIRMARY in Brooklyn, NY, will speak in the annual meeting of the European Association for the analysis of Diabetes on October 2, 2009. September 28 – October 2 in Vienna EASD is keeping its annual conference, Austria http://orlistatindia.com/xenical-generic-vs-brand.htm . Dr. Feinman will be among four speakers within the topic, Controversies in Dietary Strategies in the treating Diabetes.

BioMS Medical upgrade on dirucotide development BioMS Medical Corp. , provided an upgrade on developments according of dirucotide today, its drug applicant for multiple sclerosis : Dirucotide System Review Underway On July 27, 2009, BioMS Eli and Medical Lilly announced it had been discontinuing the medical trials evaluating dirucotide, a novel therapeutic peptide for the treating MS, to examine all available data from these scholarly studies. This technique is underway as soon as the info has been reviewed presently, BioMS Medical expects to maintain a posture to knowledgeably assess potential choices for the dirucotide medical development plan. BioMS and Eli Lilly Terminate Collaboration The special license and collaboration contract between BioMS Medical and Eli Lilly and Organization for dirucotide has been terminated with the result that all commercial privileges to dirucotide are came back to BioMS.

Other entries from category "reports":

Tag Cloud